Skip to content

SelectQuote SLQT Issuances, liabilities

Issuances, liabilities at other companies

Scansource logo
ScansourceSCSC
$0
SelectQuote logo
SelectQuoteSLQT
$0-100%
Apollo Global Management logo
Apollo Global ManagementAPO
-$89M
Corebridge Financial logo
Corebridge FinancialCRBG
$0
Evommune
 logo
Evommune EVMN
$3.32M
Roivant Sciences logo
Roivant SciencesROIV
$0-100%

Other financials

Income statement

See full
Revenue$430.9M+5.6%
Gross profit$259.6M+5.6%
Operating income$35.9M+62.9%
Net income$40.2M+54.5%
EPS (diluted)$0.11+267%

Balance sheet

See full
Cash & equivalents$35.2M-59.2%
Total debt$404.8M-4.5%
Total equity$384.7M+9.9%
Total assets$1.3B+3.0%

Cash flow

See full
Operating cash flow$56.8M-20.2%
CapEx$947.0K-0.2%
Free cash flow$55.8M-20.4%

Valuation

See full
Market cap$139.42M-65.1%
Enterprise value$509.04M-34.8%
P/E1.5×-6.9×
P/S0.1×-0.2×

Profitability

See full
Gross margin54.2%-7.6pp
Operating margin5.4%
Net margin5.6%+5.3pp
FCF margin-0.4%-3.3pp

Returns & leverage

See full
Return on equity25%+23.9pp
Debt / equity1.1×-0.2×
Current ratio1.6×-0.3×

Where this comes from

Reported directly by SelectQuote in its filing.

Tagged under the XBRL concept us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues.

The official record: SelectQuote’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about SelectQuote's issuances, liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SelectQuote's issuances, liabilities?
SelectQuote (SLQT) reported issuances, liabilities of $0 in Q1 2026.
How has SelectQuote's issuances, liabilities changed year-over-year?
SelectQuote's issuances, liabilities decreased by 100.0% year-over-year, from $128.95M to $0.
What does issuances, liabilities mean?
Reflects the reconciliation of changes in the fair value of liabilities categorized as Level 3, which rely on unobservable inputs and internal models. This metric provides transparency into the valuation methodology for complex financial instruments where market prices are not readily available. It is critical for assessing the risk and estimation uncertainty inherent in the company's balance sheet.